事実根拠 1
aggregate principal amount priced$1.3 billion
Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company"), today announced the pricing of $1.3 billion aggregate principal amount of 1....
PR Newswire news releases · 2026-10-07 04:05
証拠を見る
- 企業開示PR Newswire news releases2026-10-07 04:05
Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company"), today announced the pricing of $1.3 billion aggregate principal amount of 1....
出典を見る